Ignite Creation Date:
2025-12-25 @ 3:29 AM
Ignite Modification Date:
2026-05-31 @ 5:58 AM
Study NCT ID:
NCT03080805
Status:
UNKNOWN
Last Update Posted:
2020-06-18
First Post:
2017-03-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pyrotinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer. (PHOEBE)
Sponsor:
Jiangsu HengRui Medicine Co., Ltd.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | HER2 Positive Metastatic Breast Cancer | View |
Keywords: